Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Chinese Patent Office
Cipla
AstraZeneca
Fuji
Express Scripts
McKesson
Moodys
Citi
Merck

Generated: January 21, 2018

DrugPatentWatch Database Preview

LEVETIRACETAM IN SODIUM CHLORIDE Drug Profile

« Back to Dashboard

When do Levetiracetam In Sodium Chloride patents expire, and when can generic versions of Levetiracetam In Sodium Chloride launch?

Levetiracetam In Sodium Chloride is a drug marketed by Aurobindo Pharma Ltd, Gland Pharma Ltd, and Hq Speciality Pharma. and is included in three NDAs.

The generic ingredient in LEVETIRACETAM IN SODIUM CHLORIDE is levetiracetam. There are thirty-five drug master file entries for this compound. Ninety-nine suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
Drug patent expirations by year for LEVETIRACETAM IN SODIUM CHLORIDE
Pharmacology for LEVETIRACETAM IN SODIUM CHLORIDE

US Patents and Regulatory Information for LEVETIRACETAM IN SODIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd LEVETIRACETAM IN SODIUM CHLORIDE levetiracetam INJECTABLE;IV (INFUSION) 207160-001 Jan 4, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hq Speciality Pharma LEVETIRACETAM IN SODIUM CHLORIDE levetiracetam INJECTABLE;IV (INFUSION) 202543-001 Nov 9, 2011 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gland Pharma Ltd LEVETIRACETAM IN SODIUM CHLORIDE levetiracetam INJECTABLE;IV (INFUSION) 206880-001 Oct 25, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hq Speciality Pharma LEVETIRACETAM IN SODIUM CHLORIDE levetiracetam INJECTABLE;IV (INFUSION) 202543-002 Nov 9, 2011 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd LEVETIRACETAM IN SODIUM CHLORIDE levetiracetam INJECTABLE;IV (INFUSION) 207160-002 Jan 4, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd LEVETIRACETAM IN SODIUM CHLORIDE levetiracetam INJECTABLE;IV (INFUSION) 207160-003 Jan 4, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gland Pharma Ltd LEVETIRACETAM IN SODIUM CHLORIDE levetiracetam INJECTABLE;IV (INFUSION) 206880-003 Oct 25, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gland Pharma Ltd LEVETIRACETAM IN SODIUM CHLORIDE levetiracetam INJECTABLE;IV (INFUSION) 206880-002 Oct 25, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hq Speciality Pharma LEVETIRACETAM IN SODIUM CHLORIDE levetiracetam INJECTABLE;IV (INFUSION) 202543-003 Nov 9, 2011 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Covington
Johnson and Johnson
McKesson
QuintilesIMS
Express Scripts
Colorcon
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot